ThinkPlus Pharma Publications
3048-5428
Bi-Monthly
2023
9492805537
India
English
YES
Google Scholar
editor@jopir.in
Journal of Pharma Insights and Research (JOPIR) is a dynamic bi-monthly publication dedicated to the rapid dissemination of cutting-edge research in the fields of clinical, pharmaceutical, and biomedical sciences. Our commitment to excellence is reflected in our rigorous yet swift peer review process, ensuring that high-quality research is promptly shared with the global scientific community. This is a bimonthly journal that publishes the Research articles, Review article, Short Communications and Case Reports from the areas but not limited to Pharmaceutics, Pharmacology, Pharmaceutical Analysis, Pharmaceutical Chemistry, Medicinal Chemistry, Pharmacognosy, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry, Pharmaceutical Technology, Novel Drug Delivery, Public Health, Clinical Pharmacy, and Natural Products.
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.